Abstract Details
|
PRESENTER |
No disclosure on file |
| Hugh J. McMillan, MD (Children's Hospital of Eastern Ontario) | Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Gene Therapies. Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Gene Therapies. The institution of Dr. McMillan has received research support from Roche. |
| Richard Webster | No disclosure on file |
| No disclosure on file | |
| Aleksandra Mineyko, MD | Dr. Mineyko has nothing to disclose. |
| No disclosure on file | |
| Heather J. MacLean, MD (Ottawa General Hospital) | No disclosure on file |
| No disclosure on file | |
| Daniela Pohl | Daniela Pohl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. |